Pacific Rim Symposium on Surfaces, Coatings and Interfaces (PacSurf 2018) | |
Biomaterial Surfaces & Interfaces | Tuesday Sessions |
Session BI-TuM |
Session: | Bioimaging and Bionanotechnology |
Presenter: | Zoya Leonenko, University of Waterloo, Canada |
Authors: | E. Drolle, University of Waterloo, Canada M. Robinson, University of Waterloo, Canada B.Y. Lee, University of Waterloo, Canada C. Filice, University of Waterloo, Canada S. Turnbull, University of Waterloo, Canada N. Mei, University of Waterloo, Canada Z. Leonenko, University of Waterloo, Canada |
Correspondent: | Click to Email |
References
1. E.Drolle, K.Hammond, A.Negoda, E.Pavlov, Z.Leonenko, Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease. PLOS ONE, 2017, 12(8), e0182194.
2. B.Mehrazma, M.Robinson, S.K.A.Opare, A.Petoyan, J.Lou, F.T.Hane, A.Rauk, Z.Leonenko. Pseudo-peptide amyloid-β blocking inhibitors: molecular dynamics and single molecule force spectroscopy study. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1865 (11), 1707-1718.
3. M.Robinson, B.Y.Lee, Z.Leonenko, Drugs and Drug Delivery Systems Targeting Amyloid-β in Alzheimer’s Disease. AIMS Molecular Science, 2015, 2(3): 332-358.
4. E.Drolle, R.M.Gaikwad, Z.Leonenko, Nanoscale electrostatic domains in cholesterol-laden lipid membranes create a target for amyloid binding. Biophysical Journal, 2012, 103(4), L27-L29.
5. E.Drolle, F.Hane, B.Lee, Z.Leonenko, Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer’s disease. J. of Drug Metabolism Reviews, 2014, 46(2): 207-223.